Hepatitis B genotype and YMDD profiles in an untreated Irish population

被引:7
作者
Horgan, M [1 ]
Brannigan, E [1 ]
Crowley, B [1 ]
Levis, J [1 ]
Fanning, LJ [1 ]
机构
[1] Cork Univ Hosp, Dept Med, Mol Virol Diagnost & Res Lab, Cork, Ireland
关键词
D O I
10.1016/j.jcv.2005.08.004
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
引用
收藏
页码:203 / 204
页数:2
相关论文
共 4 条
[1]
Lee Jia-Yee, 2004, Clin Liver Dis, V8, P301, DOI 10.1016/j.cld.2004.02.009
[2]
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B [J].
Marcellin, P ;
Lau, GKK ;
Bonino, F ;
Farci, P ;
Hadziyannis, S ;
Jin, R ;
Lu, ZM ;
Piratvisuth, T ;
Germanidis, G ;
Yurdaydin, C ;
Diago, M ;
Gurel, S ;
Lai, MY ;
Button, P ;
Pluck, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (12) :1206-1217
[3]
HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C [J].
Wai, CT ;
Chu, CJ ;
Hussain, M ;
Lok, ASF .
HEPATOLOGY, 2002, 36 (06) :1425-1430
[4]
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a [J].
Zeuzem, S ;
Herrmann, E ;
Lee, JH ;
Fricke, J ;
Neumann, AU ;
Modi, M ;
Colucci, G ;
Roth, WK .
GASTROENTEROLOGY, 2001, 120 (06) :1438-1447